Table 1.
Clinical, Biochemical and Histological Features of Different Types of PFIC.
Feature | PFIC1 | PFIC2 | PFIC3 |
---|---|---|---|
Age at presentation | Infancy | Neonatal period-early infancy | Late Infancy (∼30%) to early adulthood |
End stage liver disease | First decade | Rapid, first few years | 1st to 2nd decade of life |
Course of disease | Moderately severe | Severe | Insidious |
Pruritus | Severe | Very severe | Moderate |
Extrahepatic manifestations (watery diarrhoea, pancreatitis, sensorineural deafness, short stature, abnormalities in sweat chloride) | Present | Absent | Absent |
Risk of development of liver tumors | No | High | Mild increase |
Risk of cholesterol stone disease | Absent | Increased | Increased |
Serum ALT | Mild elevation | Moderate elevation | Mild elevation |
Serum AFP | Normal | Raised | Normal |
Serum GGT | Normal | Normal | Elevated |
Serum bile acids | Raised ++ | Raised +++ | Raised + |
Bile composition | |||
Primary bile acids | Low (3–8 mM) | Very low (<1 mM) | Normal |
Phospholipids | Normal | Normal | Low |
Liver histology | Bland cholestasis, mild lobular fibrosis | Cholestasis, giant cell hepatitis, hepatocellular necrosis, portal fibrosis | Bile ductular proliferation, inflammatory infiltrate, and biliary fibrosis |
Electron microscopy | Granular bile | Amorphous bile | – |
PFIC: progressive familial intrahepatic cholestasis; GGT: gamma glutamyl transpeptidase; AFP: alpha fetoprotein; ALT: alanine aminotransferase.